Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Telehealth collaborative care program for lung cancer-related anxiety and depression

Official title: Increasing Adoption of a Telehealth-Delivered Collaborative Care Program for Patients With Lung Cancer: A Pilot Study

Run by Abramson Cancer Center at Penn Medicine · NCT07102147 · Data updated 2026-11-12

This project tests whether a more intensive 'high-touch' outreach approach gets more people with lung cancer who have anxiety or depression to join a telehealth collaborative care program than standard outreach.

More Anxiety trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorAbramson Cancer Center at Penn Medicine
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedAugust 18, 2025
Main results expectedMarch 31, 2027
Study endsJune 30, 2027
Registry record updatedMay 28, 2026
Trial IDNCT07102147 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) receiving lung cancer treatment or survivorship care at Penn Medicine Thoracic Oncology who are referred for collaborative care for depression or anxiety and are not already in external psychotherapy are ideal candidates.

Probably not a fit

Patients already receiving psychotherapy outside Penn, or those with significant untreated medical or psychiatric conditions (for example, active suicidal ideation or psychosis) may not benefit from or be eligible for this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional trial randomizes patients treated at Penn Medicine Thoracic Oncology to receive either a high-touch outreach strategy or standard outreach to invite them into a telehealth-delivered collaborative care model (CoCM) for depression and/or anxiety. The primary outcome is program reach (how many referred patients enroll and engage), and secondary outcomes include implementation measures and clinical effectiveness outcomes for mental health symptoms. Participants are adults referred to Penn's CoCM program who are not already receiving external psychotherapy, with exclusion for significant untreated medical or psychiatric comorbidities. The project builds on prior evidence that CoCM benefits patients with cancer while specifically testing whether outreach intensity increases telehealth program uptake.

Why it matters

Potential benefit: If successful, the approach could increase enrollment in effective telehealth mental health care for people with lung cancer, improving access and anxiety/depression outcomes.

How similar studies have gone: Collaborative care models have shown benefit for depression and anxiety in cancer and general populations, but using a high-touch outreach strategy to boost telehealth CoCM enrollment is a newer, pilot-level approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Are aged 18 years or older.
* Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care.
* Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services.

Exclusion Criteria:

* Are already receiving psycho-therapy treatment services outside of Penn Medicine's collaborative care program, Penn Integrated Care (PIC).
* Have a significant and/or untreated medical and/or psychiatric co-morbidity (e.g., other cancers, schizophrenia, acute suicidal and/or homicidal ideation) that make them ineligible for the Penn CoCM program.

Where it's running

  • Abramson Cancer Center at the University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.